Altered myocardial motion pattern in Fabry patients assessed with CMR-tagging

Journal of Cardiovascular Magnetic Resonance

Volumn 9, Issue 6, 2007, Pages 891-898

  Rutz, Andrea K ^a   Juli, Christoph F ^b   Ryf, Salome ^a   Widmer, Urs ^c   Kozerke, Sebastian ^a   Eckhardt, Boris P ^b   Boesiger, Peter ^a  

^a ETH ZURICH   (Switzerland)

^b CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Fabry Disease; Hypertrophy; Myocardial Contraction; Tagging

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FABRY DISEASE; FEMALE; FREQUENCY MODULATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE WALL MOTION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ROTATION; STATISTICAL ANALYSIS; TORSION;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FABRY DISEASE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING, CINE; MALE; ROTATION; TORSION ABNORMALITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36849086983     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1080/10976640701693691     Document Type: Article

References (26)

1. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Bases of Inherited Disease. 8th Ed. McGraw-Hill, New York, 2001;pp 3733-3774.
2. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 2003;108:1299-1301.
3. Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A. Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 2003;107:1978-1984.
4. Rogers WJ, Jr., Shapiro EP, Weiss JL, Buchalter MB, Rademakers FE, Weisfeldt ML, Zerhouni EA. Quantification of and correction for left ventricular systolic long-axis shortening by magnetic resonance tissue tagging and slice isolation. Circulation 1991;84:721-731.
5. Axel L, Dougherty L. Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. Radiology 1989;172:349-350.
6. Fischer SE, McKinnon GC, Maier SE, Boesiger P. Improved myocardial tagging contrast. Magn Reson Med 1993;30:191-200.
7. Osman NF, Kerwin WS, McVeigh ER, Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med 1999;42:1048-1060.
8. Fischer SE, McKinnon GC, Scheidegger MB, Prins W, Meier D, Boesiger P. True myocardial motion tracking. Magn Reson Med 1994;31:401-413.
9. Ryf S, Tsao J, Schwitter J, Stuessi A, Boesiger P. Peak-combination HARP: a method to correct for phase errors in HARP. J Magn Reson Imaging 2004;20:874-880.
10. Ashikaga H, Criscione JC, Omens JH, Covell JW, Ingels NB, Jr. Transmural left ventricular mechanics underlying torsional recoil during relaxation. Am J Physiol Heart Circ Physiol 2004;286:H640-647.
11. Stuber M, Scheidegger MB, Fischer SE, Nagel E, Steinemann F, Hess OM, Boesiger P. Alterations in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 1999;100:361-368.
12. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003;17:323-329.
13. Stuber M, Spiegel MA, Fischer SE, Scheidegger MB, Danias PG, Pedersen EM, Boesiger P. Single breath-hold slice-following CSPAMM myocardial tagging. Magma 1999;9:85-91.
14. Kuijer JP, Jansen E, Marcus JT, van Rossum AC, Heethaar RM. Improved harmonic phase myocardial strain maps. Magn Reson Med 2001;46:993-999.
15. Ryf S, Schwitter J, Spiegel MA, Rutz AK, Luechinger R, Crelier GR, Boesiger P. Accelerated tagging for the assessment of left ventricular myocardial contraction under physical stress. J Cardiovasc Magn Reson 2005;7:693-703.
16. Ryf S, Rutz AK, Boesiger P, Schwitter J. Is post-systolic shortening a reliable indicator of myocardial viability? An MR tagging and late-enhancement study. J Cardiovasc Magn Reson 2006;8:445-451.
17. Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ, Rosen BD, Lima JA, Torp H, Ihlen H, Smiseth OA. New noninvasive method for assessment of left ventricular rotation: speckle tracking echocardiography. Circulation 2005;112:3149-3156.
18. Streeter DD, Jr., Spotnitz HM, Patel DP, Ross J, Jr., Sonnenblick EH. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 1969;24:339-347.
19. Reese TG, Weisskoff RM, Smith RN, Rosen BR, Dinsmore RE, Wedeen VJ. Imagingmyocardial fiber architecture in vivo with magnetic resonance. Magn Reson Med 1995;34:786-791.
20. Weidemann F, Breunig F, Beer M, Sandstede J, Stork S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 2005;26:1221-1227.
21. Nagel E, Stuber M, Burkhard B, Fischer SE, Scheidegger MB, Boesiger P, Hess OM. Cardiac rotation and relaxation in patients with aortic valve stenosis. Eur Heart J 2000;21:582-589.
22. Delhaas T, Kotte J, van der Toorn A, Snoep G, Prinzen FW, Arts T. Increase in left ventricular torsion-to-shortening ratio in children with valvular aortic stenosis. Magn Reson Med 2004;51:135-139.
23. Oxenham HC, Young AA, Cowan BR, Gentles TL, Occleshaw CJ, Fonseca CG, Doughty RN, Sharpe N. Age-related changes in myocardial relaxation using three-dimensional tagged magnetic resonance imaging. J Cardiovasc Magn Reson 2003;5:421-430.
24. Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006;8:479-482.
25. Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-2155.
26. Barbey F, Brakch N, Linhart A, Rosenblatt-Velin N, Jeanrenaud X, Qanadli S, Steinmann B, Burnier M, Palecek T, Bultas J, Hayoz D. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 2006;26:839-844.